Current Aspects in Early-Stage NSCLC – Perspectives from ELCC23
Niels Reinmuth, a medical oncologist from Germany, presents in this MEDtalk key points from an ELCC23 symposium on early stage NSCLC that he chaired. Topics included lung cancer screening challenges, the use of TKI for resectable NSCLC patients, and data from the Pacific study of adjuvant durvalumab after chemoradiotherapy.
